CHMACHIASMA, INC

Nasdaq www.chiasmapharma.com


$ 3.76 $ 0.00 (0 %)    

Thursday, 05-Aug-2021 15:59:58 EDT
QQQ $ 469.54 $ 0.00 (0 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 3.76
-- x --
-- x --
-- - --
$ 2.77 - $ 5.74
101
na
236.25M
$ 1.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-05-2021 03-31-2021 10-Q
2 03-04-2021 12-31-2020 10-K
3 11-05-2020 09-30-2020 10-Q
4 08-10-2020 06-30-2020 10-Q
5 05-07-2020 03-31-2020 10-Q
6 03-16-2020 12-31-2019 10-K
7 11-05-2019 09-30-2019 10-Q
8 08-08-2019 06-30-2019 10-Q
9 05-09-2019 03-31-2019 10-Q
10 03-08-2019 12-31-2018 10-K
11 11-08-2018 09-30-2018 10-Q
12 08-09-2018 06-30-2018 10-Q
13 05-10-2018 03-31-2018 10-Q
14 03-20-2018 12-31-2017 10-K
15 11-09-2017 09-30-2017 10-Q
16 08-10-2017 06-30-2017 10-Q
17 05-05-2017 03-31-2017 10-Q
18 03-16-2017 12-31-2016 10-K
19 11-09-2016 09-30-2016 10-Q
20 08-11-2016 06-30-2016 10-Q
21 05-12-2016 03-31-2016 10-Q
22 03-17-2016 12-31-2015 10-K
23 11-16-2015 09-30-2015 10-Q
24 08-31-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 chiasma-reports-submission-of-marketing-authorization-application-for-mycapssa-to-european-medicines-agency

Chiasma, Inc. (NASDAQ:CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery ...

Core News & Articles

Gainers

 chiasma-highlights-presentation-of-patient-reported-outcomes-data-from-mpowered-phase-3-trial-at-annual-american-association-of-clinical-endocrinology-meeting

Chiasma, Inc. (NASDAQ:CHMA), ("Chiasma" or the "Company") today presented patient-reported outcomes (PROs) data...

 the-daily-biotech-pulse-nabriva-jumps-on-data-larimar-wilts-after-study-put-on-hold-travere-to-delay-regulatory-filing

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 the-week-ahead-in-biotech-may-23-29-eton-lantheus-fda-decisions-adcom-test-for-provention-chiasma-data-presentation

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow...

 chiasma-highlights-presentation-of-new-data-from-mpowered-phase-3-trial-at-upcoming-european-congress-of-endocrinology-annual-american-association-of-clinical-endocrinology-meetings-may-24-27

-- New clinical data accepted for oral and e-Poster presentation at AACE -- -- e-ECE clinical data previously presented at End...

 the-daily-biotech-pulse-mercks-keytruda-snags-another-fda-approval-moderna-slips-on-revenue-miss-chemocentryx-adcom

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 30-stocks-moving-in-thursdays-pre-market-session

Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 94.2% to $2.33 in pre-market trading. Stealth BioTherapeutic...

 70-biggest-movers-from-yesterday
70 Biggest Movers From Yesterday
05/06/2021 09:27:33

Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt o...

 why-chiasmas-stock-is-surging-today

Chiasma (NASDAQ:CHMA) shares are trading higher after Amryt announces that it has signed a definitive agreement to acquire Chia...

Core News & Articles

Toward the end of trading Wednesday, the Dow traded up 0.53% to 34,313.88 while the NASDAQ rose 0.18% to 13,658.26. The S&P...

Core News & Articles

Midway through trading Wednesday, the Dow traded up 0.09% to 34,162.34 while the NASDAQ rose 0.53% to 13,705.72. The S&P al...

Core News & Articles

Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 64.9% to $7.75 after the company reported an order for 200,000 sug...

Core News & Articles

Following the market opening Wednesday, the Dow traded down 0.21% to 34,060.47 while the NASDAQ rose 0.07% to 13,643.47. The S&...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION